Inside Norstella’s innovation engine: How the next generation of real-world data gets you closer to the patient

When Jeroen de Groot joined Ncardia in 2024, he stepped into a moment that many in drug discovery have been anticipating but few have navigated well. The industry has spent decades refining animal models, adjusting protocols, and searching for signals that would bring preclinical data closer to clinical reality. The limits of that approach have become increasingly difficult to ignore. Human biolog